Adding endovascular therapy to tPA didn't improve recovery after stroke

February 8, 2013

Adding endovascular therapy to clot-busting therapy for stroke did not significantly improve stroke recovery at three months, according to a study presented in a special symposium at the American Stroke Association's International Stroke Conference 2013.

The lack of benefit was despite an approximately 40 percent greater likelihood of re-opening blocked arteries and improving blood flow to the brain with endovascular treatment added to intravenous (IV) treatment with the clot-busting drug (), researchers said. "This is an important finding whether or not patients are eligible for IV tPA," said Joseph P. Broderick, M.D., study author and professor and chair of the Department of Neurology and at the University of Cincinnati College of Medicine in Ohio.

"Endovascular treatment remains an important option for since some patients with large intracranial occlusions cannot receive IV tPA during the 4.5-hour time window from stroke onset in which IV tPA is used. However, we need additional trials to better define the use of endovascular therapy."

Researchers had been hopeful that clearing vessel blockages with endovascular therapy would improve recovery from stroke.

Delivered through a vein in the arm, IV tPA is the only emergency proven to improve recovery. It must be given within 4.5 hours of and faster start of treatment with IV tPA leads to better recovery.

Endovascular therapy involves inserting a catheter directly into a blocked artery in the brain to deliver clot-busting drugs or use a device to remove the clot. This treatment has been used in patients with bigger or more stubborn clots that have not dissolved with IV t-PA or after the 4.5-hour of eligibility for treatment with intravenous clot-busting therapy.

In the Interventional Stroke Management III (IMS 3) trial, 656 patients received IV tPA within three hours of onset and 423 were randomized to receive endovascular therapy in addition to IV tPA if a clot was reveled at angiography

Researchers compared 90-day recovery of the IV tPA-plus-endovascular treatment group to the IV tPA-only group to determine if patients' recovered "functional independence," which is a modified Rankin score of 2 or lower.

They found:

  • No statistical difference in the proportion of patients achieving functional independence occurred between the two groups (40.8 percent of those receiving both therapies vs. 38.7 percent of those receiving IV tPA only).
  • Patients with the most severe strokes and those with more rapid treatment tended to have better outcomes with endovascular treatment, but the differences were not significant.
  • Death rates and bleeding in the brain that worsened the patients' clinical condition were similar for endovascular therapy and t-PA only groups.
Researchers ended the multicenter international trial early, with about two-thirds of planned participants enrolled. The trial was stopped in April 2012, after an interim analysis determined the additional therapy was highly unlikely to benefit patients.

A larger trial of patients with severe strokes and larger artery occlusions might show an effective use for endovascular therapy, researchers said.

Explore further: 'Clot-buster' drug may still be best stroke treatment

Related Stories

'Clot-buster' drug may still be best stroke treatment

February 7, 2013
(HealthDay)—The standard medical care for patients having an ischemic stroke is to give powerful "clot-busting" drugs as soon as possible after the start of the stroke.

Clot-busting medicine safe for use in warfarin-treated patients following stroke

June 26, 2012
The clot-busting medicine, tPA (tissue plasminogen activator), is safe to use in acute stroke patients already on the home blood thinner warfarin, according to researchers from Duke Clinical Research Institute (DCRI). This ...

Clot-busting drug safe for stroke patients taking blood thinner

May 10, 2012
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA), according to research presented at the American Heart Association's Quality ...

Use of clot busters for stroke increased from 2005 to 2009, but still low

June 2, 2011
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 — but is still low, according to research reported in Stroke: Journal of the American Heart Association.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.